NEW YORK (GenomeWeb News) – Pressure BioSciences said today that it has been awarded an $850,000 Phase II Small Business Innovation Research grant from the National Institutes of Health that it will use to continue development of its pressure cycling technology.
 
The funds will be provided over a two-year period, and work under the grant is expected to begin this summer. The South Easton, Mass.-based company will be collaborating with researchers at Brigham and Women’s Hospital in Boston.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The UK's Human Fertility and Embryology Authority calls for consumer genetic testing companies to warn customers that testing could uncover family secrets, according to the Guardian.

The New York Times reports that United Nations delegates have been discussing how to govern the genetic resources of the deep sea.

Researchers have transplanted edited cells into mice that appear to combat cocaine addiction, New Scientist reports.

In PNAS this week: analysis of proteolytic enzymes secreted by circulating tumor cells, phylogenetic study of Fv1 evolution, and more.